Mangalam Drugs And Organics Limited (MANGALAM.NS) share price
Mangalam Drugs And Organics Limited (NSE:MANGALAM.NS) last traded at INR 29.73, down 2.97% on the day (quote 2026-11-08 09:58 UTC), with a market cap of INR 47.1 Cr and a 52-week range of INR 22.8 to INR 64.5.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 29.73 |
| 1-day move | -2.97% |
| 52-week range | INR 22.8 - INR 64.5 |
| Market cap | INR 47.1 Cr |
| From 52-week high | -53.90% |
| Volume vs average | 0.1x |
| Falling Shares risk score | 25/100 (MODERATE) |
| Country | India |
| ISIN | INE584F01014 |
Frequently asked questions
Why is Mangalam Drugs And Organics Limited falling today?
Mangalam Drugs And Organics Limited (NSE:MANGALAM.NS) is down 2.97% at its latest quote and trades 53.9% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Mangalam Drugs And Organics Limited share price today?
Mangalam Drugs And Organics Limited (NSE:MANGALAM.NS) last traded at INR 29.73, a -2.97% move on the day as of 2026-11-08 09:58 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Mangalam Drugs And Organics Limited?
Mangalam Drugs And Organics Limited's 52-week low is INR 22.8 and its 52-week high is INR 64.5; the shares trade 53.9% below the high.
What is the market cap of Mangalam Drugs And Organics Limited?
Mangalam Drugs And Organics Limited has a market capitalisation of about INR 47.1 Cr at the latest price.
What are the risks of investing in Mangalam Drugs And Organics Limited?
Falling Shares Intelligence rates Mangalam Drugs And Organics Limited 25/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com